Microba Life Sciences, Sonic Healthcare launch MetaPanel gastrointestinal pathogen test in Australia
Microba Life Sciences Limited (ASX: MAP) has officially launched the MetaPanel product to healthcare professionals on Wednesday, 13 March 2024. This innovative product marks a ... Read More
Philips surpasses 1500 cath lab installations in India, enhancing cardiac care
Royal Philips, a global leader in health technology, announced a significant milestone at India Live 2024 in New Delhi: the completion of over 1500 Cath ... Read More
Biocon Biologics secures license agreement for biosimilar launch in US
In a landmark announcement, Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, revealed its settlement and license ... Read More
Thermo Fisher Scientific to acquire Mesa Biotech for $500m to expand point-of-care diagnostics
Thermo Fisher Scientific, a global leader in laboratory and diagnostics solutions, has finalized an agreement to acquire Mesa Biotech, a California-based point-of-care molecular diagnostic company, ... Read More
Boston Scientific’s LUMINIZE RF Balloon Catheter shows promising results in AF-FICIENT I trial
Boston Scientific has announced that its LUMINIZE Radiofrequency (RF) Balloon Catheter, developed for isolating pulmonary veins (PVs) in atrial fibrillation (AF) treatment, has demonstrated positive ... Read More
Blackstone Life Sciences and Novartis launch Anthos Therapeutics to target high-risk cardiovascular diseases
In a strategic partnership aimed at advancing cardiovascular treatments, Blackstone Life Sciences has teamed up with Swiss pharmaceutical giant Novartis to create Anthos Therapeutics, a ... Read More
GlaxoSmithKline transfers rare disease gene therapy portfolio to Orchard Therapeutics in strategic deal
GlaxoSmithKline (GSK), a leading British pharmaceutical company, has entered into a significant agreement with Orchard Therapeutics, transferring its rare disease gene therapy drugs in exchange ... Read More
EC approves Actelion’s Ledaga for treatment of cutaneous T-cell lymphoma
The European Commission (EC) has granted marketing authorization to Actelion Pharmaceuticals for its innovative Ledaga Chlormethine Gel 160 micrograms/g, designed for the treatment of cutaneous ... Read More